Latest Advances

  • Condition: Progressive Supranuclear Palsy
  • Journal: Psychiatrike = Psychiatriki
  • Treatment Used: Anodal Transcranial Direct Current Stimulation
  • Number of Patients: 8
  • Published —
This study tested the safety and efficacy of using an anodal transcranial direct current stimulation to treat patients with progressive supranuclear palsy.
  • Condition: Niemann-Pick Disease Type C (NPC)
  • Journal: Orphanet journal of rare diseases
  • Treatment Used: Hydroxypropyl-Beta Cyclodextrin (HP?PD)
  • Number of Patients: 12
  • Published —
In this study, researchers evaluated the safety and effectiveness of using IV hydroxypropyl-beta cyclodextrin (HP?PD) to treat Niemann-Pick Disease Type C (NPC).
  • Condition: Progressive supranuclear palsy
  • Journal: Brain stimulation
  • Treatment Used: Cerebellar Repetitive transcranial magnetic stimulation
  • Number of Patients: 2
  • Published —
The study researched the effects of cerebellar repetitive transcranial magnetic stimulation for progressive supranuclear palsy.
  • Condition: Progressive Supranuclear Palsy (PSP)
  • Journal: Neurology
  • Treatment Used: Transcranial Direct Current Stimulation (tDCS)
  • Number of Patients: 12
  • Published —
This study explored whether transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal cortex (DLPFC) can improve language capacities in patients with progressive supranuclear palsy (PSP).
  • Condition: Neonatal-onset Niemann-Pick Disease Type C
  • Journal: Pediatric transplantation
  • Treatment Used: Liver Transplantation
  • Number of Patients: 3
  • Published —
In this study, researchers evaluated the outcomes of liver transplantation for the treatment of neonatal-onset Niemann-Pick disease type C.
  • Condition: Niemann-Pick disease Type C (NP-C)
  • Journal: Orphanet journal of rare diseases
  • Treatment Used: Miglustat
  • Number of Patients: 63
  • Published —
This study reviewed the characteristics and factors related to disease progression for Niemann-Pick disease Type C (NP-C) and analyzed the effect of miglustat treatment on disease progression and patient survival.
Showing 1-8 of 8